$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 37 38 39 40 41 42 43 44 45 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 54.10 | 200 | 10,820 | 3,991 | 4.2 K to 4 K (-4.77 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 54.09 | 300 | 16,227 | 4,191 | 4.5 K to 4.2 K (-6.68 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 54.08 | 500 | 27,040 | 4,491 | 5 K to 4.5 K (-10.02 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 54.07 | 3,000 | 162,210 | 4,991 | 8 K to 5 K (-37.54 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 54.06 | 11,952 | 646,125 | 7,991 | 19.9 K to 8 K (-59.93 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 54.05 | 16,057 | 867,881 | 19,943 | 36 K to 19.9 K (-44.60 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 31.40 | 24,000 | 753,600 | 36,000 | 12 K to 36 K (+200.00 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 26.73 | 12,000 | 320,760 | 12,000 | 0 to 12 K |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 3.13 | 20,000 | 62,500 | 39,600 | |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.71 | 7,500 | 395,325 | 35,000 | 42.5 K to 35 K (-17.65 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.55 | 400 | 21,020 | 42,500 | 42.9 K to 42.5 K (-0.93 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.46 | 200 | 10,492 | 42,900 | 43.1 K to 42.9 K (-0.46 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.45 | 1,000 | 52,450 | 43,100 | 44.1 K to 43.1 K (-2.27 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.31 | 1,000 | 52,310 | 44,100 | 45.1 K to 44.1 K (-2.22 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.33 | 700 | 36,631 | 45,100 | 45.8 K to 45.1 K (-1.53 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.34 | 101 | 5,286 | 45,800 | 45.9 K to 45.8 K (-0.22 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.32 | 1,095 | 57,290 | 45,901 | 47 K to 45.9 K (-2.33 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.23 | 1,204 | 62,885 | 46,996 | 48.2 K to 47 K (-2.50 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.24 | 700 | 36,568 | 48,200 | 48.9 K to 48.2 K (-1.43 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.22 | 100 | 5,222 | 48,900 | 49 K to 48.9 K (-0.20 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 52.44 | 1,000 | 52,440 | 49,000 | 50 K to 49 K (-2.00 %) |
| Nov 17 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 3.13 | 20,000 | 62,500 | 50,000 | 30 K to 50 K (+66.67 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 30,000 | 352,737 | 47,824 | |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.34 | 1,300 | 70,642 | 93,021 | 94.3 K to 93 K (-1.38 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.35 | 1,400 | 76,090 | 94,321 | 95.7 K to 94.3 K (-1.46 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.36 | 400 | 21,744 | 95,721 | 96.1 K to 95.7 K (-0.42 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.37 | 17,800 | 967,786 | 96,121 | 113.9 K to 96.1 K (-15.62 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.38 | 500 | 27,190 | 113,921 | 114.4 K to 113.9 K (-0.44 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.39 | 800 | 43,512 | 114,421 | 115.2 K to 114.4 K (-0.69 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.40 | 500 | 27,200 | 115,221 | 115.7 K to 115.2 K (-0.43 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.41 | 100 | 5,441 | 115,721 | 115.8 K to 115.7 K (-0.09 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.42 | 200 | 10,884 | 115,821 | 116 K to 115.8 K (-0.17 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.44 | 500 | 27,220 | 116,021 | 116.5 K to 116 K (-0.43 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.45 | 600 | 32,670 | 116,521 | 117.1 K to 116.5 K (-0.51 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.46 | 200 | 10,892 | 117,121 | 117.3 K to 117.1 K (-0.17 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.48 | 400 | 21,792 | 117,321 | 117.7 K to 117.3 K (-0.34 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.50 | 700 | 38,150 | 117,721 | 118.4 K to 117.7 K (-0.59 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.51 | 600 | 32,706 | 118,421 | 119 K to 118.4 K (-0.50 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | P | 54.53 | 400 | 21,812 | 119,021 | 119.4 K to 119 K (-0.33 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.54 | 300 | 16,362 | 119,421 | 119.7 K to 119.4 K (-0.25 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.55 | 600 | 32,730 | 119,721 | 120.3 K to 119.7 K (-0.50 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.56 | 2,200 | 120,032 | 120,321 | 122.5 K to 120.3 K (-1.80 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 54.59 | 500 | 27,295 | 122,521 | 123 K to 122.5 K (-0.41 %) |
| Nov 22 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 30,000 | 352,737 | 123,021 | 93 K to 123 K (+32.25 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 7.40 | 50,000 | 369,925 | 26,000 | |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.36 | 600 | 28,416 | 9,751 | 10.4 K to 9.8 K (-5.80 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.43 | 300 | 14,229 | 10,351 | 10.7 K to 10.4 K (-2.82 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.42 | 100 | 4,742 | 10,651 | 10.8 K to 10.7 K (-0.93 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.40 | 7,100 | 336,540 | 10,751 | 17.9 K to 10.8 K (-39.77 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.41 | 1,500 | 71,115 | 17,851 | 19.4 K to 17.9 K (-7.75 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.39 | 1,400 | 66,346 | 19,351 | 20.8 K to 19.4 K (-6.75 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.38 | 1,000 | 47,380 | 20,751 | 21.8 K to 20.8 K (-4.60 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.37 | 100 | 4,737 | 21,751 | 21.9 K to 21.8 K (-0.46 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.35 | 400 | 18,940 | 21,851 | 22.3 K to 21.9 K (-1.80 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.34 | 400 | 18,936 | 22,251 | 22.7 K to 22.3 K (-1.77 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.33 | 700 | 33,131 | 22,651 | 23.4 K to 22.7 K (-3.00 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.32 | 2,000 | 94,640 | 23,351 | 25.4 K to 23.4 K (-7.89 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.30 | 1,500 | 70,950 | 25,351 | 26.9 K to 25.4 K (-5.59 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.31 | 1,200 | 56,772 | 26,851 | 28.1 K to 26.9 K (-4.28 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.26 | 500 | 23,630 | 28,051 | 28.6 K to 28.1 K (-1.75 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.25 | 19,100 | 902,475 | 28,551 | 47.7 K to 28.6 K (-40.08 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | S | 47.46 | 200 | 9,492 | 47,651 | 47.5 K to 47.7 K (+0.42 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.45 | 6,100 | 289,445 | 47,851 | 54 K to 47.9 K (-11.31 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.44 | 1,700 | 80,648 | 53,951 | 55.7 K to 54 K (-3.05 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.49 | 2,500 | 118,725 | 55,651 | 58.2 K to 55.7 K (-4.30 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.48 | 1,500 | 71,220 | 58,151 | 59.7 K to 58.2 K (-2.51 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 47.47 | 100 | 4,747 | 59,651 | 59.8 K to 59.7 K (-0.17 %) |
| Oct 27 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 7.40 | 50,000 | 369,925 | 59,751 | 9.8 K to 59.8 K (+512.77 %) |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 4.09 | 20,000 | 81,876 | 0 | |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 51.76 | 100 | 5,176 | 30,000 | 30.1 K to 30 K (-0.33 %) |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 51.83 | 7,500 | 388,725 | 30,100 | 37.6 K to 30.1 K (-19.95 %) |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 51.92 | 800 | 41,536 | 37,600 | 38.4 K to 37.6 K (-2.08 %) |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 51.91 | 1,200 | 62,292 | 38,400 | 39.6 K to 38.4 K (-3.03 %) |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 51.95 | 4,000 | 207,800 | 39,600 | 43.6 K to 39.6 K (-9.17 %) |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 51.98 | 200 | 10,396 | 43,600 | 43.8 K to 43.6 K (-0.46 %) |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 51.96 | 1,200 | 62,352 | 43,800 | 45 K to 43.8 K (-2.67 %) |
| Nov 14 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 4.09 | 20,000 | 81,876 | 45,000 | 25 K to 45 K (+80.00 %) |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 7.41 | 13,496 | 99,955 | 0 | |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 7.40 | 100,000 | 739,850 | 96,488 | |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Gift | G | 0.00 | 2,500 | 0 | 89,822 | 92.3 K to 89.8 K (-2.71 %) |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 47.51 | 20,000 | 950,200 | 505,069 | 525.1 K to 505.1 K (-3.81 %) |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 47.57 | 10,000 | 475,700 | 525,069 | 535.1 K to 525.1 K (-1.87 %) |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 47.55 | 20,000 | 951,000 | 535,069 | 555.1 K to 535.1 K (-3.60 %) |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 47.76 | 15,000 | 716,400 | 555,069 | 570.1 K to 555.1 K (-2.63 %) |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 47.77 | 35,000 | 1,671,950 | 570,069 | 605.1 K to 570.1 K (-5.78 %) |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 7.41 | 13,496 | 99,955 | 605,069 | 591.6 K to 605.1 K (+2.28 %) |
| Oct 26 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 7.40 | 100,000 | 739,850 | 591,573 | 491.6 K to 591.6 K (+20.34 %) |
| Aug 31 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 42.08 | 400 | 16,832 | 146,615 | 147 K to 146.6 K (-0.27 %) |
| Aug 31 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 42.06 | 300 | 12,618 | 147,015 | 147.3 K to 147 K (-0.20 %) |
| Aug 31 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 42.07 | 3,800 | 159,866 | 147,315 | 151.1 K to 147.3 K (-2.51 %) |
| Aug 31 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 42.11 | 1,000 | 42,110 | 151,115 | 152.1 K to 151.1 K (-0.66 %) |
| Aug 31 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 42.12 | 1,500 | 63,180 | 152,115 | 153.6 K to 152.1 K (-0.98 %) |
| Aug 31 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 42.14 | 2,000 | 84,280 | 153,615 | 155.6 K to 153.6 K (-1.29 %) |
| Aug 31 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 42.16 | 500 | 21,080 | 155,615 | 156.1 K to 155.6 K (-0.32 %) |
| Aug 31 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 42.14 | 500 | 21,070 | 156,115 | 156.6 K to 156.1 K (-0.32 %) |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 7.40 | 110,000 | 813,835 | 196,488 | |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 7.30 | 13,704 | 99,997 | 0 | |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 42.10 | 50,000 | 2,105,000 | 491,573 | 541.6 K to 491.6 K (-9.23 %) |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 42.11 | 10,000 | 421,100 | 541,573 | 551.6 K to 541.6 K (-1.81 %) |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 42.12 | 30,000 | 1,263,600 | 551,573 | 581.6 K to 551.6 K (-5.16 %) |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 42.22 | 20,000 | 844,400 | 581,573 | 601.6 K to 581.6 K (-3.32 %) |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 7.40 | 110,000 | 813,835 | 601,573 | 491.6 K to 601.6 K (+22.38 %) |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 7.30 | 13,704 | 99,997 | 491,573 | 477.9 K to 491.6 K (+2.87 %) |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Option Exercise | M | 4.00 | 200,000 | 800,000 | 0 | |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Option Exercise | M | 4.75 | 16,000 | 76,000 | 0 | |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Buy | M | 4.00 | 200,000 | 800,000 | 402,648 | 202.6 K to 402.6 K (+98.69 %) |
| Aug 18 2005 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Buy | M | 4.75 | 16,000 | 76,000 | 202,648 | 186.6 K to 202.6 K (+8.57 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 4.09 | 4,000 | 16,375 | 20,000 | |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 4.75 | 16,000 | 76,000 | 0 | |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.45 | 1,900 | 80,655 | 25,000 | 26.9 K to 25 K (-7.06 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.43 | 1,205 | 51,128 | 26,900 | 28.1 K to 26.9 K (-4.29 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.42 | 3,885 | 164,802 | 28,105 | 32 K to 28.1 K (-12.14 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.41 | 426 | 18,067 | 31,990 | 32.4 K to 32 K (-1.31 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.40 | 774 | 32,818 | 32,416 | 33.2 K to 32.4 K (-2.33 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.39 | 1,300 | 55,107 | 33,190 | 34.5 K to 33.2 K (-3.77 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.38 | 415 | 17,588 | 34,490 | 34.9 K to 34.5 K (-1.19 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.37 | 467 | 19,787 | 34,905 | 35.4 K to 34.9 K (-1.32 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.36 | 1,215 | 51,467 | 35,372 | 36.6 K to 35.4 K (-3.32 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.35 | 1,318 | 55,817 | 36,587 | 37.9 K to 36.6 K (-3.48 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.34 | 1,300 | 55,042 | 37,905 | 39.2 K to 37.9 K (-3.32 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 42.33 | 795 | 33,652 | 39,205 | 40 K to 39.2 K (-1.99 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 4.09 | 4,000 | 16,375 | 40,000 | 36 K to 40 K (+11.11 %) |
| Aug 11 2005 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 4.75 | 16,000 | 76,000 | 36,000 | 20 K to 36 K (+80.00 %) |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | A | 43.97 | 50,000 | 2,198,500 | 50,000 | |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | D | 8.34 | 10,000 | 83,360 | 5,010 | |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 45.00 | 10,000 | 450,000 | 19,354 | 29.4 K to 19.4 K (-34.07 %) |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 8.34 | 10,000 | 83,360 | 29,354 | 19.4 K to 29.4 K (+51.67 %) |
| Aug 10 2005 | GILD | GILEAD SCIENCES IN ... | SHULTZ GEORGE P | Director | Gift | G | 0.00 | 25,000 | 0 | 55,000 | 80 K to 55 K (-31.25 %) |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP Research and PP ... | Option Exercise | A | 43.97 | 30,000 | 1,319,100 | 30,000 | |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | A | 43.97 | 50,000 | 2,198,500 | 50,000 | |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | A | 43.97 | 30,000 | 1,319,100 | 30,000 | |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | CARACCIOLO ANTHONY | SVP | Option Exercise | A | 43.97 | 30,000 | 1,319,100 | 30,000 | |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 43.97 | 6,000 | 263,820 | 6,000 | |
| Jul 29 2005 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 43.97 | 30,000 | 1,319,100 | 30,000 | |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 3.27 | 50,000 | 163,285 | 450,360 | |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 4.09 | 66,720 | 273,138 | 0 | |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.76 | 9,200 | 411,792 | 683,577 | 692.8 K to 683.6 K (-1.33 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.75 | 40,800 | 1,825,800 | 692,777 | 733.6 K to 692.8 K (-5.56 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.75 | 18,400 | 823,400 | 733,577 | 752 K to 733.6 K (-2.45 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.77 | 8,400 | 376,068 | 751,977 | 760.4 K to 752 K (-1.10 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.79 | 7,400 | 331,446 | 760,377 | 767.8 K to 760.4 K (-0.96 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.78 | 18,600 | 832,908 | 767,777 | 786.4 K to 767.8 K (-2.37 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.80 | 9,400 | 421,120 | 786,377 | 795.8 K to 786.4 K (-1.18 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.83 | 3,200 | 143,456 | 795,777 | 799 K to 795.8 K (-0.40 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 44.85 | 1,320 | 59,202 | 798,977 | 800.3 K to 799 K (-0.16 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 3.27 | 50,000 | 163,285 | 800,297 | 750.3 K to 800.3 K (+6.66 %) |
| Jul 28 2005 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 4.09 | 66,720 | 273,138 | 750,297 | 683.6 K to 750.3 K (+9.76 %) |
| Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 29,320 | 344,742 | 77,824 | |
| Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 7.41 | 680 | 5,036 | 0 | |
| Jul 26 2005 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 44.01 | 400 | 17,604 | 93,021 | 93.4 K to 93 K (-0.43 %) |